Huisheng Biological announced that it intends to issue convertible bonds to raise no more than 700 million yuan, which will be used for the expansion project of annual production line of 1000 tons of tylosin and 600tons of tylosin.
The chairman of the company is Zhang Weiyuan. Zhang Weiyuan, male, born in 1969, Chinese nationality, master of business administration and bachelor degree in animal husbandry and veterinary medicine, senior veterinarian, no permanent residence abroad. He once served as a technician in Wuhan chicken breeding farm and the person in charge of Wuhan Huaxing Feed Science and Technology Development Co., Ltd. Founded in January 2002, Huisheng Co., Ltd. has served as a director and general manager of the company. The current chairman and general manager of the company.
This article is compiled by the Securities Star data Center according to the public data and does not constitute investment opinions or suggestions. If you have any questions, please contact us.